[Federal Register Volume 81, Number 186 (Monday, September 26, 2016)]
[Notices]
[Pages 66029-66030]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-23053]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee.
Time and Date:
8:00 a.m.-6:00 p.m., EDT, October 19, 2016
8:00 a.m.-3:30 p.m., EDT, October 20, 2016
Place: CDC, Tom Harkin Global Communications Center, 1600 Clifton
Road NE., Building 19, Kent ``Oz'' Nelson Auditorium, Atlanta, Georgia
30329.
Status: Open to the public, limited only by the space available.
Time will be available for public comment. The public is welcome to
submit written comments in advance of the meeting. Comments should be
submitted in writing by email to the contact person listed below. The
deadline for receipt is October 11, 2016. All written comments must
contain the name, address, and organizational affiliation of the
speaker, as well as the topic being addressed. Written comments should
not exceed one single-spaced typed page in length and delivered in 3
minutes or less. Please note that the public comment period may end
before the time indicated, following the last call for comments.
Members of the public who wish to provide public comments should plan
to attend the public comment session at the start time listed. Written
comments received in advance
[[Page 66030]]
of the meeting will be included in the official record of the meeting.
The meeting will be webcast live via the World Wide Web; for
instructions and more information on ACIP please visit the ACIP Web
site: http://www.cdc.gov/vaccines/acip/index.html.
Purpose: The committee is charged with advising the Director, CDC,
on the appropriate use of immunizing agents. In addition, under 42
U.S.C. Sec. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contraindications applicable to
the vaccines. Further, under provisions of the Affordable Care Act, at
section 2713 of the Public Health Service Act, immunization
recommendations of the ACIP that have been adopted by the Director of
the Centers for Disease Control and Prevention and appear on the CDC
immunization schedules must be covered by applicable health plans.
Matters for Discussion: The agenda will include discussions on:
Meningococcal vaccines; human papillomavirus vaccines; influenza;
hepatitis vaccines; pertussis vaccines; Respiratory Syncytial Virus
(RSV); child and adolescent immunization schedule; adult immunization
schedule; herpes zoster vaccine; yellow fever vaccine; pneumococcal
vaccine and vaccine supply. A recommendation vote is scheduled for
Hepatitis B vaccine, pertussis vaccine, human papillomavirus vaccines,
meningococcal vaccines, child and adolescent immunization schedule, and
adult immunization schedule. A Vaccines for Children (VFC) vote is
scheduled for human papillomavirus vaccines, Hepatitis B vaccine and
meningococcal vaccines. Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Stephanie Thomas, National
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton
Road NE., MS-A27, Atlanta, Georgia 30329, Telephone: (404) 639-8836;
Email: [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention and the Agency for
Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2016-23053 Filed 9-23-16; 8:45 am]
BILLING CODE 4160-18-P